Bluejay Diagnostics (NASDAQ:BJDX) just reported results for the fourth quarter of 2023.
- Bluejay Diagnostics reported earnings per share of -$1.78. This was below the analyst estimate for EPS of -68 cents.
- The company did not report any revenue for the quarter.